What is the likely cause of gray discoloration of the outer third of a child's eyes and what is the appropriate management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gray Discoloration of the Outer Third of a Child's Eyes

The most likely diagnosis is ocular melanocytosis (nevus of Ota when involving periocular skin), which presents as gray-blue or slate-gray pigmentation of the sclera and conjunctiva, typically in the interpalpebral zone, and requires lifelong ophthalmologic surveillance for glaucoma and melanoma. 1

Clinical Presentation and Diagnosis

Gray or slate-blue discoloration of the sclera in children most commonly represents oculodermal melanocytosis (ODM) or isolated ocular melanocytosis, caused by dermal melanocytes in the episclera and sclera 1. This condition:

  • Appears as patchy gray-blue pigmentation, most visible in the interpalpebral zone (outer third of the eye) 1
  • Predominantly affects Asian populations and females 1
  • May be unilateral or bilateral 1
  • Can involve conjunctiva, sclera, cornea, iris, ciliary body, and choroid 1

Key distinguishing features to assess:

  • Iris heterochromia (darker iris on affected side) is the most typical ocular sign 1
  • Iris mammillations (dome-shaped protuberances) indicate higher malignant transformation risk 1
  • Periocular facial skin hyperpigmentation confirms oculodermal melanocytosis (nevus of Ota) versus isolated ocular melanocytosis 2, 1

Immediate Management

Refer to pediatric ophthalmology for comprehensive examination including 3:

  • Cycloplegic refraction to assess refractive error 3
  • Intraocular pressure measurement to screen for glaucoma 3, 1
  • Gonioscopy to evaluate angle abnormalities 1
  • Dilated fundus examination to assess choroidal involvement 1
  • Documentation of iris pigmentation patterns and any mammillations 1

Long-Term Surveillance Protocol

Establish routine ophthalmologic monitoring because ocular melanocytosis carries significant risks 1:

  • Glaucoma risk: Occurs from angle abnormalities or mechanical occlusion by melanocytes in the trabecular meshwork 1
  • Melanoma risk: Choroidal and ciliary body melanoma have higher incidence in melanocytosis 1, 4
  • Iris melanoma: Can arise even in young patients from sector iris pigmentation 4

The 13-year-old case report demonstrates that melanoma can develop in childhood from ocular melanocytosis, emphasizing the need for periodic examination starting early 4.

Critical Pitfalls to Avoid

Do not dismiss gray scleral pigmentation as benign without establishing surveillance, as both glaucoma and melanoma complications can develop insidiously 1. The presence of iris mammillations specifically indicates elevated malignant transformation risk and warrants more frequent monitoring 1.

Do not confuse ocular melanocytosis with other pigmentary disorders such as conjunctival nevi (which are focal, not diffuse) or primary acquired melanosis (which develops later in life, not congenitally) 5.

Do not overlook associated systemic conditions in children with pigmentary disorders, as neurologic development abnormalities can accompany congenital melanocytic conditions 2.

References

Research

Ocular manifestations of pigmentary disorders.

Dermatologic clinics, 1992

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pigmented conjunctival and scleral lesions.

Mayo Clinic proceedings, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.